Related scientific articles (all)

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

Authors : Thouvenin J, Alhalabi O, Carlo M, Carril-Ajuria L, Hirsch L, Martinez-Chanza N, Négrier S, Campedel L, Martini D, Borchiellini D, Chahoud J, Lodi M, Barthélémy P, Hasanov E, Hahn AW, Gil T, Viswanathan SR, Bakouny Z, Msaouel P, Asim Bilen M, Choueiri TK, Albiges L, Tannir NM, Malouf GG
Year : 2022
Journal : Oncologist
Volume : 27
Pages : 1041-1047

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.

Authors : Gerratana L, Pierga JY, Reuben JM, Davis AA, Wehbe FH, Dirix L, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Bonotto M, Fernandez de Lascoiti A, De Mattos-Arruda L, Ignatiadis M, Sandri MT, Generali D, de Angelis C, Dawson SJ, Janni W, Carañana V, Riethdorf S, Solomayer EF, Puglisi F, Giuliano M, Pantel K, Bidard FC, Cristofanilli M
Year : 2022
Journal : Oncologist
Volume : 27
Pages : e561-e570

Cytokine Landscape in Central Nervous System Metastases.

Authors : Marin J, Journe F, Ghanem GE, Awada A, Kindt N
Year : 2022
Journal : Biomedicines
Volume : 10

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate.

Authors : Poggio F, Tagliamento M, Ceppi M, Bruzzone M, Conte B, Fregatti P, Punie K, de Azambuja E, Del Mastro L, Lambertini M
Year : 2022
Journal : Ann Oncol
Volume : 33
Pages : 347-349

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.

Authors : Arboleda B, Bartsch R, de Azambuja E, Hamilton E, Harbeck N, Klemp J, Knauer M, Kuemmel S, Mahtani R, Schwartzberg L, Villarreal-Garza C, Wolff A
Year : 2022
Journal : Oncologist
Volume : 27
Pages : 722-731

Endoscopic submucosal dissection of a solitary gastric plasmacytoma: third space oddity"."

Authors : Rasschaert G, Gkolfakis P, Eisendrath P, Verset L, Devière J, Lemmers A
Year : 2022
Journal : Endoscopy
Volume : 54
Pages : E732-E734

FUS::CREM-rearranged malignant epithelioid neoplasm mimicking neuroendocrine neoplasm of unknown primary.

Authors : Demetter P, Awada A, Aftimos P, Liberale G, Jungels C, Gomez-Galdon M, Saiselet M, de Saint Aubain N
Year : 2022
Journal : Histopathology
Volume : 80
Pages : 871-873

Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis.

Authors : Rothé F, Venet D, Peeters D, Rouas G, Rediti M, Smeets D, Dupont F, Campbell P, Lambrechts D, Dirix L, Sotiriou C, Ignatiadis M
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 79

Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era.

Authors : Capdevila J, Awada A, Führer-Sakel D, Leboulleux S, Pauwels P
Year : 2022
Journal : Cancer Treat Rev
Volume : 106
Pages : 102380

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.

Authors : Geyer CE Jr, Garber JE, Gelber Rd, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ
Year : 2022
Journal : Ann Oncol
Volume : 33
Pages : 1250-1268

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Authors : Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA
Year : 2022
Journal : N Engl J Med
Volume : 387
Pages : 9-20

The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancer.

Authors : Isnaldi E, Richard F, De Schepper M, Leduc S, Maetens M, Geukens T, Van Baelen K, Nguyen HL, Rouas G, Zoppoli G, Cardoso F, Sotiriou C, Larsimont D, Floris G, Biganzoli E, Desmedt C
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 90

The first ones now, will later be last": understanding the importance of historical context when reading ESMO-MCBS scores."

Authors : Cherny NI, Dafni U, Pentheroudakis G, Piccart-Gebhart M, Zygoura P, Gyawali B, de Vries EGE
Year : 2022
Journal : ESMO Open
Volume : 7
Pages : 100413

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142.

Authors : André T, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Abdullaev S, Memaj A, Lei M, Dixon M, Kopetz S, Overman MJ
Year : 2022
Journal : Ann Oncol
Volume : 33
Pages : 1052-1060

CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.

Authors : Karam A, Mjaess G, Martinez Chanza N, Aoun F, Bou Kheir G, Younes H, Kazzi H, Albisinni S, Roumeguère T
Year : 2022
Journal : Cancer Invest
Pages : 1-15

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Authors : Carey LA, Loirat D, Punie K, Bardia A, Diéras V, Dalenc F, Diamond JR, Fontaine C, Wang G, Rugo HS, Hurvitz SA, Kalinsky K, OShaughnessy J, Loibl S, Gianni L, Piccart M, Zhu Y, Delaney R, Phan S, Cortés J
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 72

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 38

Circulating DNA in the neoadjuvant setting of early stage colon cancer.

Authors : Bregni G, Pretta A, Senti C, Acedo Reina E, Vandeputte C, Trevisi E, Gkolfakis P, Kehagias P, Deleporte A, Van Laethem JL, Vergauwe P, Van den Eynde M, Deboever G, Janssens J, Demolin G, Holbrechts S, Clausse M, De Grez T, Peeters M, DHondt L, Geboes K, Besse-Hammer T, Rothé F, Flamen P, Hendlisz A, Sclafani F
Year : 2022
Journal : Acta Oncol
Volume : 61
Pages : 1223-1229

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.

Authors : Agostinetto E, Ameye L, Martel S, Aftimos P, Pondé N, Maurer C, El-Abed S, Wang Y, Vicente M, Chumsri S, Bliss J, Kroep J, Colleoni M, Petrelli F, Del Mastro L, Moreno-Aspitia A, Piccart M, Paesmans M, de Azambuja E, Lambertini M
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 87

Polypoid colon mucosa in a leukemia patient.

Authors : Lifrange F, Van Gossum A, Verset L, Bron D, Gomez-Galdon M, Demetter P
Year : 2022
Journal : Acta Gastroenterol Belg
Volume : 85
Pages : 118-119